newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

The private placement includes participation from several leading healthcare investors including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management and Nazare PartnersProceeds expected to enable CNS